FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292362088> ?p ?o ?g. }

• W4292362088 endingPage "587" @default.
• W4292362088 startingPage "580" @default.
• W4292362088 abstract "The mechanism underlying the antiepileptic actions of norepinephrine (NE) is unclear with conflicting results. Our objectives are to conclusively delineate the specific adrenergic receptor (AR) involved in attenuating hippocampal CA3 epileptiform activity and assess compounds for lead drug development. We utilized the picrotoxin model of seizure generation in rat brain slices using electrophysiological recordings. Epinephrine (EPI) reduced epileptiform burst frequency in a concentration-dependent manner. To identify the specific receptor involved in this response, the equilibrium dissociation constants were determined for a panel of ligands and compared with established binding values for α1, α2, and other receptor subtypes. Correlation and slope of unity were found for the α2A-AR, but not other receptors. Effects of different chemical classes of α-AR agonists at inhibiting epileptiform activity by potency (pEC50) and relative efficacy (RE) were determined. Compared with NE (pEC50, 6.20; RE, 100%), dexmedetomidine, an imidazoline (pEC50, 8.59; RE, 67.1%), and guanabenz, a guanidine (pEC50, 7.94; RE, 37.9%), exhibited the highest potency (pEC50). In contrast, the catecholamines, EPI (pEC50, 6.95; RE, 120%) and α-methyl-NE (pEC50, 6.38; RE, 116%) were the most efficacious. These findings confirm that CA3 epileptiform activity is mediated solely by α2A-ARs without activation of other receptor systems. These findings suggest a pharmacotherapeutic target for treating epilepsy and highlight the need for selective and efficacious α2A-AR agonists that can cross the blood–brain barrier." @default.
• W4292362088 created "2022-08-20" @default.
• W4292362088 creator A5006889718 @default.
• W4292362088 creator A5011902958 @default.
• W4292362088 creator A5017239795 @default.
• W4292362088 creator A5032240532 @default.
• W4292362088 creator A5032925328 @default.
• W4292362088 creator A5034138387 @default.
• W4292362088 creator A5041537880 @default.
• W4292362088 creator A5071397609 @default.
• W4292362088 creator A5078415178 @default.
• W4292362088 creator A5088074924 @default.
• W4292362088 date "2022-08-19" @default.
• W4292362088 modified "2023-09-25" @default.
• W4292362088 title "Pharmacological characterization of the α_2A-adrenergic receptor inhibiting rat hippocampal CA3 epileptiform activity: comparison of ligand efficacy and potency" @default.
• W4292362088 cites W1568201961 @default.
• W4292362088 cites W1601065938 @default.
• W4292362088 cites W1967699704 @default.
• W4292362088 cites W1968721836 @default.
• W4292362088 cites W1974799637 @default.
• W4292362088 cites W1983622677 @default.
• W4292362088 cites W1984689203 @default.
• W4292362088 cites W1989869379 @default.
• W4292362088 cites W2017331060 @default.
• W4292362088 cites W2026043108 @default.
• W4292362088 cites W2046598682 @default.
• W4292362088 cites W2057971042 @default.
• W4292362088 cites W2079634519 @default.
• W4292362088 cites W2085889525 @default.
• W4292362088 cites W2091436862 @default.
• W4292362088 cites W2097094466 @default.
• W4292362088 cites W2108553691 @default.
• W4292362088 cites W2132403112 @default.
• W4292362088 cites W2800274927 @default.
• W4292362088 cites W2991808202 @default.
• W4292362088 cites W2992752039 @default.
• W4292362088 cites W3010356478 @default.
• W4292362088 cites W4220688771 @default.
• W4292362088 doi "https://doi.org/10.1080/10799893.2022.2110896" @default.
• W4292362088 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35984443" @default.
• W4292362088 hasPublicationYear "2022" @default.
• W4292362088 type Work @default.
• W4292362088 citedByCount "1" @default.
• W4292362088 countsByYear W42923620882022 @default.
• W4292362088 crossrefType "journal-article" @default.
• W4292362088 hasAuthorship W4292362088A5006889718 @default.
• W4292362088 hasAuthorship W4292362088A5011902958 @default.
• W4292362088 hasAuthorship W4292362088A5017239795 @default.
• W4292362088 hasAuthorship W4292362088A5032240532 @default.
• W4292362088 hasAuthorship W4292362088A5032925328 @default.
• W4292362088 hasAuthorship W4292362088A5034138387 @default.
• W4292362088 hasAuthorship W4292362088A5041537880 @default.
• W4292362088 hasAuthorship W4292362088A5071397609 @default.
• W4292362088 hasAuthorship W4292362088A5078415178 @default.
• W4292362088 hasAuthorship W4292362088A5088074924 @default.
• W4292362088 hasBestOaLocation W42923620881 @default.
• W4292362088 hasConcept C126322002 @default.
• W4292362088 hasConcept C134018914 @default.
• W4292362088 hasConcept C148762608 @default.
• W4292362088 hasConcept C168258287 @default.
• W4292362088 hasConcept C169760540 @default.
• W4292362088 hasConcept C170493617 @default.
• W4292362088 hasConcept C185592680 @default.
• W4292362088 hasConcept C202751555 @default.
• W4292362088 hasConcept C2778186239 @default.
• W4292362088 hasConcept C2778938600 @default.
• W4292362088 hasConcept C2779324764 @default.
• W4292362088 hasConcept C38533456 @default.
• W4292362088 hasConcept C55493867 @default.
• W4292362088 hasConcept C57992300 @default.
• W4292362088 hasConcept C71924100 @default.
• W4292362088 hasConcept C74998103 @default.
• W4292362088 hasConcept C86803240 @default.
• W4292362088 hasConcept C98274493 @default.
• W4292362088 hasConceptScore W4292362088C126322002 @default.
• W4292362088 hasConceptScore W4292362088C134018914 @default.
• W4292362088 hasConceptScore W4292362088C148762608 @default.
• W4292362088 hasConceptScore W4292362088C168258287 @default.
• W4292362088 hasConceptScore W4292362088C169760540 @default.
• W4292362088 hasConceptScore W4292362088C170493617 @default.
• W4292362088 hasConceptScore W4292362088C185592680 @default.
• W4292362088 hasConceptScore W4292362088C202751555 @default.
• W4292362088 hasConceptScore W4292362088C2778186239 @default.
• W4292362088 hasConceptScore W4292362088C2778938600 @default.
• W4292362088 hasConceptScore W4292362088C2779324764 @default.
• W4292362088 hasConceptScore W4292362088C38533456 @default.
• W4292362088 hasConceptScore W4292362088C55493867 @default.
• W4292362088 hasConceptScore W4292362088C57992300 @default.
• W4292362088 hasConceptScore W4292362088C71924100 @default.
• W4292362088 hasConceptScore W4292362088C74998103 @default.
• W4292362088 hasConceptScore W4292362088C86803240 @default.
• W4292362088 hasConceptScore W4292362088C98274493 @default.
• W4292362088 hasFunder F4320306076 @default.
• W4292362088 hasFunder F4320337354 @default.
• W4292362088 hasIssue "6" @default.
• W4292362088 hasLocation W42923620881 @default.
• W4292362088 hasLocation W42923620882 @default.
• W4292362088 hasOpenAccess W4292362088 @default.

• next